. may 16, 2018
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
http://lm360.us/Sipes-grandma-of-Klett-from-Bischheim?Nulischda=115
. may 15, 2018
.
.
.
us opioid crisis hits indian pharma companies